Andrew Callos insider trades

Open-market stock purchases and sales by Andrew Callos, EVP, Chief Commercial Officer at Cytokinetics Inc, from SEC Form 4 filings since Mar 31, 2021.

Recent trades

DateStockTradeValue
Aug 31, 2026CYTK Cytokinetics IncSold$702K
Aug 31, 2026CYTK Cytokinetics IncBought (not open market)—
Jul 30, 2026CYTK Cytokinetics IncSold$1.1M
Jul 30, 2026CYTK Cytokinetics IncBought (not open market)—
Jun 1, 2026CYTK Cytokinetics IncSold$1.1M
Jun 1, 2026CYTK Cytokinetics IncBought (not open market)—
May 5, 2026CYTK Cytokinetics IncSold$875K
May 5, 2026CYTK Cytokinetics IncBought (not open market)—
May 1, 2026CYTK Cytokinetics IncSold$1M
May 1, 2026CYTK Cytokinetics IncBought (not open market)—
Apr 30, 2026CYTK Cytokinetics IncSold$949K
Apr 30, 2026CYTK Cytokinetics IncBought (not open market)—
Apr 15, 2026CYTK Cytokinetics IncSold$492K
Mar 31, 2026CYTK Cytokinetics IncSold$237K
Mar 18, 2026CYTK Cytokinetics IncSold$120K
Mar 17, 2026CYTK Cytokinetics IncSold$350K
Mar 17, 2026CYTK Cytokinetics IncSold$181K
Mar 16, 2026CYTK Cytokinetics IncSold$104K
Mar 15, 2026CYTK Cytokinetics IncBought (not open market)—
Mar 15, 2026CYTK Cytokinetics IncBought (not open market)—
Mar 15, 2026CYTK Cytokinetics IncBought (not open market)—
Mar 15, 2026CYTK Cytokinetics IncBought (not open market)—
Mar 9, 2026CYTK Cytokinetics IncSold$157K
Mar 5, 2026CYTK Cytokinetics IncSold$681K
Mar 5, 2026CYTK Cytokinetics IncBought (not open market)—

Companies traded

  • CYTK Cytokinetics Inc: 33 sales, last Aug 31, 2026

Get free alerts when Andrew Callos files a new trade →